(Q40160155)

18 September 2017

Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis (English)

1 reference

18 September 2017

G Brien

1

1 reference

18 September 2017

M-C Trescol-Biemont

series ordinal

2

1 reference

18 September 2017

N Bonnefoy-Bérard

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

12 March 2007

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

5828-5832

1 reference

18 September 2017

39

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210363

18 September 2017

0 references

cites work

Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

State-of-the-art therapeutics: diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen-induced T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Molecular diagnosis of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

NF- B1 p50 Is Required for BLyS Attenuation of Apoptosis but Dispensable for Processing of NF- B2 p100 to p52 in Quiescent Mature B Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Prostate stem cell antigen is overexpressed in prostate cancer metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Apoptosis-based therapies for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Regulation of A1/Bfl-1 expression in peripheral splenic B cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Involvement of the bcl-2 gene in human follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Life in the balance: how BH3-only proteins induce apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210363

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210363

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference